Pear Therapeutics

Pear Therapeutics

Pear Therapeutics

Pear discovers, develops, and commercializes Prescription Digital Therapeutics to treat diseases with high unmet need.
Founded
2013
Raised
$154M
Follow us
Alexa global traffic share
Latest funding Show all
$64,000,000
Venture capital (Series C) - 2019
Temasek Holdings Novartis EDBI +9
$50,000,000
Venture capital (Series B) - 2018
Novartis EDBI 5AM Ventures +4
Team Size
10+
Employees
$64,000,000 Venture capital (Series C)
PE HUB

Pear Therapeutics locks in $64 mln Series C

$50,000,000 Venture capital (Series B)
PE HUB

| PEAR Therapeutics scores $50 mln Series B

$20,000,000 Venture capital
VentureWire , FinSMEs

The Daily Startup: Pear Therapeutics Aims for Digital Substance-Abuse Treatment

Funding
$20,000,000 Venture capital (Series UNDISCLOSED)
PRWeb

Digital Therapeutics Pioneer Pear Therapeutics Raises $20M